Clinical Trial Update: Pharmacokinetics of Ingenol Mebutate Gel in Actinic Keratosis Under Maximum Use Conditions [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study evaluating Ingenol Mebutate Gel in actinic keratosis under maximum use conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• Ingenol Mebutate Gel (ingenol mebutate)

Snippet

Sponsor: LEO Pharma | Conditions: Actinic Keratosis | Phase 1 | Status: COMPLETED